The Dixie Group, Inc. (NASDAQ:DXYN) shares fell -6.04% in last trading session and ended the day at $5.60. DXYN Gross Margin is 24.80% and its has a return on assets of -2.30%. The Dixie Group, Inc. (NASDAQ:DXYN) quarterly performance is -45.04%.
TheStreet cut shares of Dixie Group (NASDAQ:DXYN) from a hold rating to a sell rating in a report released on Friday morning, Market Beat reports.
South Jersey Industries, Inc. (NYSE:SJI) ended the last trading day at $21.47. Company weekly volatility is calculated as 2.40% and price to cash ratio as 708.41. South Jersey Industries, Inc. (NYSE:SJI) showed a weekly performance of -1.13%.
South Jersey Industries, Inc. (NYSE:SJI) board of directors considers when setting the dividend include future earnings expectations, payout ratio, and dividend yield relative to those at peer companies as well as returns available on other income oriented investments. The dividend is payable December 29, 2015 to shareholders of record at the close of business December 10, 2015.
On 14 December, Eaton Vance Corp. (NYSE:EV) shares fell -3.73% and was closed at $31.24. EV EPS growth in last 5 year was 6.90%. Eaton Vance Corp. (NYSE:EV) year to date (YTD) performance is -21.66%.
Eaton Vance Corp. (NYSE:EV) will reportedly roll out its ambitious NextShares funds in Feb 2016. Notably, the Boston-based investment manager has received final nod from the U.S. Securities and Exchange Commission (“SEC”) for an initial launch of 18 NextShares funds.
Acceleron Pharma, Inc. (NASDAQ:XLRN) shares advanced 1.14% in last trading session and ended the day at $42.53. XLRN has a return on assets of -31.70%. Acceleron Pharma, Inc. (NASDAQ:XLRN) quarterly performance is 21.17%.
Celgene Corporation (NASDAQ:CELG) and Acceleron Pharma Inc. (NASDAQ:XLRN) announced preliminary results from two Phase 2 clinical trials of luspatercept in patients with beta-thalassemia were presented at the 57th American Society of Hematology (ASH) Annual Meeting and Exposition. Results highlighted in an oral presentation showed that luspatercept increased hemoglobin levels, reduced transfusion burden, improved health-related quality of life measures and had beneficial effects on liver iron concentration in patients with beta-thalassemia. Celgene and Acceleron are jointly developing luspatercept.
Silver Spring Networks, Inc. (NYSE:SSNI) caters to the Technology space. It has a net profit margin of 5.10% and weekly performance is -4.14%. On the last day of trading company shares ended up at $14.11. Silver Spring Networks, Inc. (NYSE:SSNI) distance from 50-day simple moving average (SMA50) is 1.88%.
On 9 December, at a ceremony at San Jose City Hall, Silver Spring Networks, Inc. (NYSE:SSNI) announced Starfish, an international wireless IPv6 network service for the Internet of Things. Silver Spring has already delivered more than 22 million connected devices for IoT networks on five continents. Building on this footprint, Starfish will enable commercial enterprises, cities, utilities, and developers to access a reliable, secure, and scalable IoT network service with service level agreements (SLAs) that meet their needs. Starfish will first be available in the North American cities of Chicago, San Antonio, and San Jose; the European cities of Bristol, Copenhagen, and Glasgow; and in Calcutta, India. Silver Spring intends to expand Starfish’s IoT service coverage across North America, Latin America, Europe, Asia, Australia, and New Zealand throughout 2016 and beyond.
Leave a Reply